Speakers
Peter Downs has more than 30 years of experience as a business and medical journalist and investigative reporter. He has written for a variety of…
Read More
Mr. Evanson has served as our Chief Commercial Officer since November 2018. Mr. Evanson joined Outlook Therapeutics from Scott Three Consulting where he was the…
Read More
Dr. Chang is presently Professor of Ophthalmology at Columbia University Medical Center in New York. He was the first to use C3F8 gas in the…
Read More
Dr. Aaron Osborne has 15 years of experience in the biopharmaceutical industry together which have been mainly focused on developing therapies for retinal disease. He…
Read More
Suber S. Huang, MD, MBA, FASRS is CEO of the Retina Center of Ohio, Voluntary Assistant Clinical Professor Bascom Palmer Eye Institute, University of Miami,…
Read More
Mr. Hallen has 34 years of uniquely broad ophthalmic experience in Marketing, Sales, Manufacturing, Quality, R&D, and Acquisitions. Paul is currently serving as Vice President…
Read More
Dr. Carl Awh (pronounced “Oh”) is an internationally recognized clinician, surgeon, and educator. He completed a fellowship in Vitreoretinal Surgery and Research at the Duke…
Read More
Neil is a Director in Navigant’s Life Sciences practice and has over 15 years experience managing both strategic and tactical projects across EMEA. Neil has…
Read More
Dr. John McInnes, a board-certified ophthalmologist, brings his medical experience to bear for life sciences clients navigating complex regulatory challenges. He rejoins the firm after…
Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.
![OIS-ANTERIOR-NEW-DATE-750x420[4300]](https://ois.net/wp-content/uploads/2020/03/OIS-ANTERIOR-NEW-DATE-750x4204300.jpg "OIS-ANTERIOR-NEW-DATE-750x420[4300]")